Works by Girish, Sandhya

Results: 61

Contradistinction between doxorubicin and epirubicin: in-vivo metabolism, pharmacokinetics and toxicodynamics after single- and multiple-dosing in rats.

Published in:

Journal of Pharmacy & Pharmacology, 2001, v. 53, n. 7, p. 987, doi. 10.1211/0022357011776234

By:

Ramanathan-Girish, Sandhya;
Boroujerdi, Mehdi

Publication type:

Article

Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood components.

Published in:

Journal of Pharmacy & Pharmacology, 2001, v. 53, n. 6, p. 815, doi. 10.1211/0022357011776162

By:

Ramanathan-Girish, Sandhya;
Boroujerdi, Mehdi

Publication type:

Article

PHARMACOKINETICS INFORMS REMDESIVIR DOSING FOR PATIENTS WITH SEVERE RENAL IMPAIRMENT.

Published in:

Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 201

By:

Humeniuk, Rita;
Deng, Rong;
Sorribes, Inmaculada C.;
Regan, Sean;
Haeyoung Zhang;
Robson, Richard;
Sise, Meghan;
Koullias, Yiannis;
Llewellyn, Joe;
Hyland, Robert;
Osinusi, Anu;
Girish, Sandhya;
Ruiz-Garcia, Ana;
Winter, Helen

Publication type:

Article

POPULATION PK ANALYSIS TO GUIDE DOSING WINDOW FOLLOWING LENACAPAVIR SC ADMINISTRATION.

Published in:

Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 198

By:

Shaik, Naveed A.;
Bellanti, Francesco;
Comisar, Craig;
Rhee, Martin S.;
Girish, Sandhya;
Palaparthy, Ramesh;
Singh, Renu

Publication type:

Article

Effect of Food Intake or Coadministration With an Acid‐Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 4, p. 324, doi. 10.1002/cpdd.1513

By:

Singh, Renu;
Shelton, Mark;
Olson, Isabel;
Ling, John;
West, Steve;
Levy, Jeffrey A.;
Rhee, Martin S.;
Girish, Sandhya;
Palaparthy, Ramesh

Publication type:

Article

Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 144, doi. 10.1002/cpdd.847

By:

Cheeti, Sravanthi;
Deng, Yuzhong;
Chang, Ilsung;
Georgescu, Isabela;
Templeton, Ian;
Choong, Nicholas;
Cheung, Kit Wun Kathy;
Girish, Sandhya;
Musib, Luna

Publication type:

Article

Exposure–Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple‐Negative Breast Cancer.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 570, doi. 10.1002/cpt.3495

By:

Sathe, Abhishek G.;
Diderichsen, Paul M.;
Fauchet, Floris;
Phan, See‐Chun;
Girish, Sandhya;
Othman, Ahmed A.

Publication type:

Article

Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 26, doi. 10.1002/cpt.3242

By:

Mohamed, Mohamed‐Eslam F.;
Girish, Sandhya;
Humeniuk, Rita;
Nuthalapati, Silpa;
Desai, Amit;
Datta‐Mannan, Amita;
Gheyas, Ferdous;
Kanodia, Jitendra;
Cheeti, Sravanthi;
Zhu, Tong

Publication type:

Article

Correction to: Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Published in:

2022

By:

Wang, Bei;
Deng, Rong;
Hennig, Stefanie;
Badovinac Crnjevic, Tanja;
Kaewphluk, Monika;
Kågedal, Matts;
Quartino, Angelica L.;
Girish, Sandhya;
Li, Chunze;
Kirschbrown, Whitney P.

Publication type:

Correction Notice

Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Published in:

Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 499, doi. 10.1007/s00280-021-04296-0

By:

Wang, Bei;
Deng, Rong;
Hennig, Stefanie;
Badovinac Crnjevic, Tanja;
Kaewphluk, Monika;
Kågedal, Matts;
Quartino, Angelica L.;
Girish, Sandhya;
Li, Chunze;
Kirschbrown, Whitney P.

Publication type:

Article

Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 347, doi. 10.1007/s00280-020-04119-8

By:

Shi, Rong;
Lu, Tong;
Ku, Grace;
Ding, Hao;
Saito, Tomohisa;
Gibiansky, Leonid;
Agarwal, Priya;
Li, Xiaobin;
Jin, Jin Yan;
Girish, Sandhya;
Miles, Dale;
Li, Chunze;
Lu, Dan

Publication type:

Article

Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma.

Published in:

2020

By:

Shemesh, Colby S.;
Agarwal, Priya;
Lu, Tong;
Lee, Calvin;
Dere, Randall C.;
Li, Xiaobin;
Li, Chunze;
Jin, Jin Y.;
Girish, Sandhya;
Miles, Dale;
Lu, Dan

Publication type:

journal article

Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting.

Published in:

2019

By:

Morrissey, Kari M.;
Marchand, Mathilde;
Patel, Hina;
Zhang, Rong;
Wu, Benjamin;
Phyllis Chan, H.;
Mecke, Almut;
Girish, Sandhya;
Jin, Jin Y.;
Winter, Helen R.;
Bruno, René

Publication type:

journal article

Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.

Published in:

2019

By:

Kirschbrown, Whitney P.;
Wang, Bei;
Nijem, Ihsan;
Ohtsu, Atsushi;
Hoff, Paulo M.;
Shah, Manish A.;
Shen, Lin;
Kang, Yoon-Koo;
Alsina, Maria;
Girish, Sandhya;
Garg, Amit

Publication type:

journal article

Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer.

Published in:

2019

By:

Lu, Dan;
Li, Chunze;
Riggs, Matthew;
Polhamus, Daniel;
French, Jonathan;
Agarwal, Priya;
Chen, Shang-Chiung;
Vadhavkar, Shweta;
Patre, Monika;
Strasak, Alexander;
Quartino, Angelica;
Jin, Jin Yan;
Girish, Sandhya

Publication type:

journal article

Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.

Published in:

2019

By:

Kirschbrown, Whitney P.;
Kågedal, Matts;
Wang, Bei;
Lindbom, Lars;
Knott, Adam;
Mack, Rachelle;
Monemi, Sharareh;
Nijem, Ihsan;
Girish, Sandhya;
Freeman, Christie;
Fumagalli, Debora;
McConnell, Robin;
Jerusalem, Guy;
Twelves, Chris;
Baselga, José;
von Minckwitz, Gunter;
Bines, José;
Garg, Amit

Publication type:

journal article

Correction to: Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).

Published in:

2018

By:

Chen, Shang-Chiung;
Kagedal, Matts;
Gao, Yuying;
Wang, Bei;
Harle-Yge, Marie-Laurence;
Girish, Sandhya;
Jin, Jin;
Li, Chunze

Publication type:

journal article

Exposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.

Published in:

2017

By:

Li, Chunze;
Wang, Bei;
Chen, Shang-Chiung;
Wada, Russell;
Lu, Dan;
Wang, Xin;
Polhamus, Daniel;
French, Jonathan;
Vadhavkar, Shweta;
Strasak, Alexander;
Smitt, Melanie;
Joshi, Amita;
Samant, Meghna;
Quartino, Angelica;
Jin, Jin;
Girish, Sandhya

Publication type:

journal article

Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).

Published in:

2017

By:

Chen, Shang-Chiung;
Kagedal, Matts;
Gao, Yuying;
Wang, Bei;
Harle-Yge, Marie-Laurence;
Girish, Sandhya;
Jin, Jin;
Li, Chunze

Publication type:

journal article

Ethnic sensitivity assessment of the antibody-drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer.

Published in:

2016

By:

Li, Chunze;
Wang, Bei;
Lu, Dan;
Jin, Jin;
Gao, Yuying;
Matsunaga, Kiyoshi;
Igawa, Yuriko;
Nijem, Ihsan;
Lu, Michael;
Strasak, Alexander;
Chernyukhin, Nataliya;
Girish, Sandhya;
Jin, Jin Y

Publication type:

journal article

Population pharmacokinetics of bevacizumab in cancer patients with external validation.

Published in:

2016

By:

Han, Kelong;
Peyret, Thomas;
Marchand, Mathilde;
Quartino, Angelica;
Gosselin, Nathalie;
Girish, Sandhya;
Allison, David;
Jin, Jin;
Gosselin, Nathalie H;
Allison, David E

Publication type:

journal article

Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 399, doi. 10.1007/s00280-014-2500-2

By:

Lu, Dan;
Girish, Sandhya;
Gao, Yuying;
Wang, Bei;
Yi, Joo-Hee;
Guardino, Ellie;
Samant, Meghna;
Cobleigh, Melody;
Rimawi, Mothaffar;
Conte, Pierfranco;
Jin, Jin

Publication type:

Article

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 4, p. 591, doi. 10.1007/s00280-012-1934-7

By:

Bender, Brendan;
Schaedeli-Stark, Franziska;
Koch, Reinhold;
Joshi, Amita;
Chu, Yu-Waye;
Rugo, Hope;
Krop, Ian;
Girish, Sandhya;
Friberg, Lena;
Gupta, Manish

Publication type:

Article

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.

Published in:

2012

By:

Girish S;
Gupta M;
Wang B;
Lu D;
Krop IE;
Vogel CL;
Burris Iii HA;
Lorusso PM;
Yi JH;
Saad O;
Tong B;
Chu YW;
Holden S;
Joshi A;
Girish, Sandhya;
Gupta, Manish;
Wang, Bei;
Lu, Dan;
Krop, Ian E;
Vogel, Charles L

Publication type:

journal article

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1229, doi. 10.1007/s00280-011-1817-3

By:

Girish, Sandhya;
Gupta, Manish;
Wang, Bei;
Lu, Dan;
Krop, Ian;
Vogel, Charles;
Burris III, Howard;
LoRusso, Patricia;
Yi, Joo-Hee;
Saad, Ola;
Tong, Barbara;
Chu, Yu-Waye;
Holden, Scott;
Joshi, Amita

Publication type:

Article

Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2905, doi. 10.1080/10428194.2020.1795154

By:

Lu, Tong;
Gibiansky, Leonid;
Li, Xiaobin;
Li, Chunze;
Shi, Rong;
Agarwal, Priya;
Hirata, Jamie;
Miles, Dale;
Chanu, Pascal;
Girish, Sandhya;
Jin, Jin Yan;
Lu, Dan

Publication type:

Article

Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 1, p. 56, doi. 10.1080/10428194.2019.1657575

By:

Deng, Rong;
Gibiansky, Leonid;
Lu, Tong;
Li, Xiaobin;
Lu, Dan;
Li, Chunze;
Girish, Sandhya;
Wang, Jue;
Boyer, Michelle;
Shankar, Noopur;
Humphrey, Kathryn;
Freise, Kevin J.;
Salem, Ahmed Hamed;
Seymour, John F.;
Kater, Arnon P.;
Miles, Dale

Publication type:

Article

Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2017, v. 44, n. 6, p. 537, doi. 10.1007/s10928-017-9544-y

By:

Kågedal, Matts;
Gibiansky, Leonid;
Xu, Jian;
Wang, Xin;
Samineni, Divya;
Chen, Shang-Chiung;
Lu, Dan;
Agarwal, Priya;
Wang, Bei;
Saad, Ola;
Koppada, Neelima;
Fine, Bernard;
Jin, Jin;
Girish, Sandhya;
Li, Chunze

Publication type:

Article

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2493, doi. 10.1111/bcp.14662

By:

Kawakatsu, Sonoko;
Bruno, René;
Kågedal, Matts;
Li, Chunze;
Girish, Sandhya;
Joshi, Amita;
Wu, Benjamin

Publication type:

Article

Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2767, doi. 10.1111/bcp.13381

By:

Chen, Shang‐Chiung;
Quartino, Angelica;
Polhamus, Daniel;
Riggs, Matthew;
French, Jonathan;
Wang, Xin;
Vadhavkar, Shweta;
Smitt, Melanie;
Hoersch, Silke;
Strasak, Alexander;
Jin, Jin Yan;
Girish, Sandhya;
Li, Chunze

Publication type:

Article

AAPS Workshop Report: Strategies to Address Therapeutic Protein-Drug Interactions during Clinical Development.

Published in:

2011

By:

Girish, Sandhya;
Martin, Steven;
Peterson, Mark;
Zhang, Lei;
Zhao, Hong;
Balthasar, Joseph;
Evers, Raymond;
Zhou, Honghui;
Zhu, Min;
Klunk, Lewis;
Han, Chao;
Berglund, Eva;
Huang, Shiew-Mei;
Joshi, Amita

Publication type:

Report

Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma.

Published in:

Pharmaceutical Research, 2020, v. 37, n. 12, p. 1, doi. 10.1007/s11095-020-02933-6

By:

Lu, Dan;
Lu, Tong;
Shi, Rong;
Gibiansky, Leonid;
Agarwal, Priya;
Shemesh, Colby S.;
Dere, Randall C.;
Ogbu, Uzor;
Hirata, Jamie;
Chanu, Pascal;
Girish, Sandhya;
Jin, Jin Yan;
Li, Chunze;
Miles, Dale

Publication type:

Article

Correction to: Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.

Published in:

2018

By:

Cheeti, Sravanthi;
Hou, Hao Helen;
Nelson, Eric;
Walker, Helen;
Chen, Buyun;
Morley, Roland;
Gates, Mary;
Musib, Luna;
Girish, Sandhya;
Sahasranaman, Srikumar;
Liu, Lichuan

Publication type:

Correction Notice

Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.

Published in:

Pharmaceutical Research, 2018, v. 35, n. 12, p. 1, doi. 10.1007/s11095-018-2516-0

By:

Cheeti, Sravanthi;
Hou, Hao Helen;
Nelson, Eric;
Walker, Helen;
Chen, Buyun;
Morley, Roland;
Gates, Mary;
Musib, Luna;
Girish, Sandhya;
Sahasranaman, Srikumar;
Liu, Lichuan

Publication type:

Article

A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory.

Published in:

Pharmaceutical Research, 2018, v. 35, n. 6, p. 1, doi. 10.1007/s11095-018-2403-8

By:

Schindler, Emilie;
Friberg, Lena E.;
Lum, Bertram L.;
Bei Wang;
Quartino, Angelica;
Chunze Li;
Girish, Sandhya;
Jin, Jin Y.;
Karlsson, Mats O.

Publication type:

Article

Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys.

Published in:

Pharmaceutical Research, 2015, v. 32, n. 6, p. 1907, doi. 10.1007/s11095-014-1585-y

By:

Lu, Dan;
Jin, Jin;
Girish, Sandhya;
Agarwal, Priya;
Li, Dongwei;
Prabhu, Saileta;
Dere, Randall;
Saad, Ola;
Nazzal, Denise;
Koppada, Neelima;
Ramanujan, Saroja;
Ng, Chee

Publication type:

Article

Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 5, p. 669, doi. 10.1007/s40262-024-01366-3

By:

Sathe, Abhishek G.;
Singh, Indrajeet;
Singh, Pratap;
Diderichsen, Paul M.;
Wang, Xiaohui;
Chang, Peter;
Taqui, Atiya;
Phan, See;
Girish, Sandhya;
Othman, Ahmed A.

Publication type:

Article

Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.

Published in:

2019

By:

Deng, Rong;
Gibiansky, Leonid;
Lu, Tong;
Agarwal, Priya;
Ding, Hao;
Li, Xiaobin;
Kshirsagar, Smita;
Lu, Dan;
Li, Chunze;
Girish, Sandhya;
Wang, Jue;
Boyer, Michelle;
Humphrey, Kathryn;
Freise, Kevin J.;
Salem, Ahmed Hamed;
Seymour, John F.;
Kater, Arnon P.;
Miles, Dale

Publication type:

journal article

A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.

Published in:

2017

By:

Li, Chunze;
Agarwal, Priya;
Gibiansky, Ekaterina;
Jin, Jin;
Dent, Susan;
Gonçalves, Anthony;
Nijem, Ihsan;
Strasak, Alexander;
Harle-Yge, Marie-Laurence;
Chernyukhin, Nataliya;
LoRusso, Pat;
Girish, Sandhya;
Jin, Jin Yan;
Gonçalves, Anthony

Publication type:

journal article

Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates.

Published in:

Clinical Pharmacokinetics, 2015, v. 54, n. 1, p. 81, doi. 10.1007/s40262-014-0182-x

By:

Chen, Yuan;
Samineni, Divya;
Mukadam, Sophie;
Wong, Harvey;
Shen, Ben-Quan;
Lu, Dan;
Girish, Sandhya;
Hop, Cornelis;
Jin, Jin;
Li, Chunze

Publication type:

Article

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer.

Published in:

Clinical Pharmacokinetics, 2013, v. 52, n. 8, p. 657, doi. 10.1007/s40262-013-0060-y

By:

Lu, Dan;
Joshi, Amita;
Wang, Bei;
Olsen, Steve;
Yi, Joo-Hee;
Krop, Ian;
Burris, Howard;
Girish, Sandhya

Publication type:

Article

Modeling the Interplay Between Viral and Immune Dynamics in HIV: A Review and Mrgsolve Implementation and Exploration.

Published in:

CTS: Clinical & Translational Science, 2025, v. 18, n. 2, p. 1, doi. 10.1111/cts.70160

By:

Vegas Rodriguez, Alberto;
Velez de Mendizábal, Nieves;
Girish, Sandhya;
Trocóniz, Iñaki F.;
Feigelman, Justin S.

Publication type:

Article

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.

Published in:

CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2276, doi. 10.1111/cts.13627

By:

Humeniuk, Rita;
Juneja, Kavita;
Chen, Shuguang;
Ellis, Scott;
Anoshchenko, Olena;
Xiao, Deqing;
Share, Aaron;
Johnston, Matthew;
Davies, Santosh;
DeZure, Adam;
Llewellyn, Joe;
Osinusi, Anu;
Winter, Helen;
Girish, Sandhya;
Palaparthy, Ramesh;
Dresser, Mark

Publication type:

Article

Integrating real‐world data to accelerate and guide drug development: A clinical pharmacology perspective.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 10, p. 2293, doi. 10.1111/cts.13379

By:

Zhao, Xiaochen;
Iqbal, Shahed;
Valdes, Ivelisse L.;
Dresser, Mark;
Girish, Sandhya

Publication type:

Article

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 8, p. 1818, doi. 10.1111/cts.13312

By:

Kasichayanula, Sreeneeranj;
Mandlekar, Sandhya;
Shivva, Vittal;
Patel, Maulik;
Girish, Sandhya

Publication type:

Article

Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1).

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 1, p. 130, doi. 10.1111/cts.13127

By:

Wu, Benjamin;
Sternheim, Nitzan;
Agarwal, Priya;
Suchomel, Julia;
Vadhavkar, Shweta;
Bruno, Rene;
Ballinger, Marcus;
Bernaards, Coen A.;
Chan, Phyllis;
Ruppel, Jane;
Jin, Jin;
Girish, Sandhya;
Joshi, Amita;
Quarmby, Valerie

Publication type:

Article

Collaborations between Clinical Pharmacologists in Japan and in the United States ‐ Report from the IQ CPLG and JPMA CPTF Meeting in Tokyo, Japan.

Published in:

CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 102, doi. 10.1111/cts.12853

By:

Zhu, Tong;
Kayama, Makoto;
Girish, Sandhya;
Sinha, Vikram;
Bello, Akintunde;
Kawaguchi, Atsuhiro;
Czerniak, Richard;
Nagao, Lee

Publication type:

Article

Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data.

Published in:

CTS: Clinical & Translational Science, 2019, v. 12, n. 5, p. 534, doi. 10.1111/cts.12649

By:

Li, Chunze;
Zhang, Cindy;
Deng, Rong;
Leipold, Douglas;
Li, Dongwei;
Latifi, Brandon;
Gao, Yuying;
Zhang, Crystal;
Li, Zao;
Miles, Dale;
Chen, Shang‐Chiung;
Samineni, Divya;
Wang, Bei;
Agarwal, Priya;
Lu, Dan;
Prabhu, Saileta;
Girish, Sandhya;
Kamath, Amrita V.

Publication type:

Article

A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer.

Published in:

Cancer (0008543X), 2012, v. 118, n. 23, p. 5733, doi. 10.1002/cncr.27622

By:

Beeram, Muralidhar;
Krop, Ian E.;
Burris, Howard A.;
Girish, Sandhya R.;
Yu, Wei;
Lu, Michael W.;
Holden, Scott N.;
Modi, Shanu

Publication type:

Article

Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 6, p. 533, doi. 10.1080/17512433.2023.2219446

By:

Singh, Pratap;
Rotte, Anand;
Golsorkhi, Anthony A.;
Girish, Sandhya

Publication type:

Article